Page 12 - L:\GROUP\SDT\zip_disk\Book2.PDF
P. 12

S Step 1  Conduct a TB Risk Assessmenttep 1  Conduct a TB Risk Assessment




          Conduct a risk assessment for the entire facility
          and for specific areas within the facility.  The          admission until acid-fast bacilli (AFB)
          elements of the risk assessment are included              specimens ordered;
          below for complete information on how to con-             AFB specimens ordered until AFB
          duct the assessment.  Perform a follow-up risk            specimens collected;
          assessment at the intervals indicated by the most         AFB specimens collected until AFB
          recent risk assessment [CDC 1994, Figure 1,               smears performed and reported;
          Table 2].  Determine who must wear a respirator           AFB specimens collected until cultures
          and be included in the program.                           performed and reported;
                                                                    AFB specimens collected until species

           TABLE 1.  Elements of a risk assessment                  identification conducted and reported;
           for tuberculosis (TB) in health care facili-             AFB specimens collected until drug-
           ties (Reprinted from [CDC 1994, page 8])                 susceptibility tests performed and
                                                                    reported;
             1.  Review the community TB profile                    admission until TB isolation initiated;
             (from public health department data).                  admission until TB treatment initiated;
                                                                    and duration of TB isolation.
             2.  Review the number of TB patients
             who were treated in each area of the                  Obtain the following additional information:
             facility (both inpatient and outpatient).
             (This information can be obtained by                   Were appropriate criteria used for dis-
             analyzing laboratory surveillance data                 continuing isolation?
             and by reviewing discharge diagnoses or                Did the patient have a history of prior
             medical and infection-control records.)                admission to the facility?
                                                                    Was the TB treatment regiment
             3.  Review the drug-susceptibility pat-                adequate?
             terns of TB isolates of patients who were              Were follow-up sputum specimens
             treated at the facility.                               collected properly?
                                                                    Was appropriate discharge planning
             4.  Analyze purified protein derivative                conducted?
             (PPD)-tuberculin skin-test results of
             health care workers (HCWs), by area or               6.  Perform an observational review of TB
             by occupational group for HCWs not                   infection control practices.
             assigned to a specific area (e.g., respira-
             tory therapists).                                    7.  Review the most recent environmental
                                                                  evaluation and maintenance procedures.
             5.  To evaluate infection-control param-
             eters, review medical records of a sample         Copies of the Morbidity and Mortality Weekly
             of TB patients seen at the facility.              Report (October 28, 1994/Vol. 43/No. RR-13)
                                                               entitled "Guidelines for Preventing the Transmis-
             Calculate intervals from:                         sion of Mycobacterium tuberculosis in Health Care
                    admission until TB suspected;              Facilities, 1994" may be obtained by calling
                    admission until TB evaluation              1-800-843-6356 or is available through the CDC
                    performed;                                 homepage at http://www.cdc.gov.



                                                            4
   7   8   9   10   11   12   13   14   15   16   17